| NCT ID | NCT03740529 |
| Title | A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Loxo Oncology, Inc. |
| Indications | |
| Therapies |
Cyclophosphamide + Doxorubicin + LOXO-305 + Prednisone + Rituximab + Vincristine Sulfate |
| Age Groups: | adult senior |